<DOC>
	<DOCNO>NCT02180269</DOCNO>
	<brief_summary>The purpose study evaluate safety , tolerability , pharmacokinetics ( PK , study way drug enters leave blood tissue time ) single-ascending oral dos JNJ-54861911 healthy Japanese male participant .</brief_summary>
	<brief_title>A Safety , Tolerability Pharmacokinetics Study JNJ-54861911 Healthy Japanese Male Participants</brief_title>
	<detailed_description>This single-center , randomize ( study medication assign participant chance ) , double-blind ( neither Investigator participant know treatment participant receives ) , placebo control ( placebo inactive substance compare drug test whether drug real effect clinical trial ) , study single-ascending dose JNJ-54861911 participant 55 75 year age . The duration study approximately 2 6 week per participant . The study consist 3 period : Screening period ( 28 2 day prior dose administration ) ; Double-blind Treatment period ( participant receive either single oral dose JNJ-54861911 placebo tablet fast condition ) ; Follow-up visit period ( 7 14 day dose administration ) . All eligible participant assign follow 3 cohort : Cohort A ( single oral dose JNJ-54861911 , 25 milligram [ mg ] placebo ) ; Cohort B ( single oral dose JNJ-54861911 , 50 mg placebo ) ; Cohort C ( single oral dose JNJ-54861911 , 100 mg placebo ) . Each cohort include 8 participant . Participants cohort randomly assign receive either single oral dose JNJ-54861911 ( n = 6 ) placebo ( n = 2 ) . Blood sample collect pre-dose 96 hour ( Day 5 ) dose understand PK characteristic JNJ-54861911 . Participants ' safety monitor throughout study .</detailed_description>
	<criteria>Signed informed consent document indicate understand purpose procedure require study , willing participate study A man , sexually active woman childbearing potential vasectomy , must agree use adequate contraception method deem appropriate investigator , must donate sperm study 90 day receive study drug Body mass index 18 30 kilogram ( kg ) per square meter Blood pressure ( supine 5 minute ) 90 150 millimeter mercury ( mm Hg ) systolic , high 90 mm Hg diastolic Must healthy basis physical neurological examination , medical history , vital sign , 12lead electrocardiogram ( ECG ) perform screen admission ( Day 1 predose ) History current liver renal impairment , significant cardiac , vascular , pulmonary , gastrointestinal , endocrine , neurologic , hematologic , rheumatologic , psychiatric , dermatological ( puncture site ) metabolic disturbance History spontaneous , prolong severe bleed unclear origin History epilepsy fit History human immunodeficiency virus ( HIV ) antigen/antibody positive , test positive HIV screening</criteria>
	<gender>Male</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Healthy</keyword>
	<keyword>JNJ-54861911</keyword>
	<keyword>Alzheimer 's disease</keyword>
</DOC>